𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Portopulmonary hypertension and the issue of survival

✍ Scribed by Michael J. Krowka

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
45 KB
Volume
11
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Female sex and autoimmune hepatitis and
Female sex and autoimmune hepatitis and the risk of portopulmonary hypertension
✍ Gustavo CastaΓ±o; Silvia Sookoian πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 57 KB

We read with great interest the article by Kawut et al. regarding the clinical risk factors for portopulmonary hypertension (PPHTN) in a multicenter case-control epidemiologic study. 1 The authors demonstrated that women with liver disease have a higher risk than men of developing PPHTN. They have a

Assessment of acute pulmonary vascular r
Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension
✍ Giovanni L. Ricci; Maria Teresa Melgosa; Felip Burgos; JosΓ© Luis Valera; Sandra πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 211 KB

The role of acute pulmonary vasodilator testing in portopulmonary hypertension (PoPH), a current contraindication for orthotopic liver transplantation (OLT), has not been thoroughly elucidated. The purpose of this work was to analyze the results of acute vasodilator testing with inhaled nitric oxide

Acute and long-term effects of inhaled i
Acute and long-term effects of inhaled iloprost in portopulmonary hypertension
✍ Maria Teresa Melgosa; Giovanni L. Ricci; Juan Carlos GarcΓ­a-Pagan; Isabel Blanco πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 172 KB

Portopulmonary hypertension (PoPH) is a serious condition without an established treatment. Drugs used to treat pulmonary hypertension may have detrimental effects on portal hypertension. This study was designed to assess in patients with PoPH the acute effects of inhaled iloprost (iILO) on pulmonar